|
Titre: Oramed Says Oral Insulin Succeeds In Midstage Type 2 Diabetes Trial Posté par: RosettaFen sur Juin 12, 2016, 02:29:41 According to management, the rationale for the inventory option grants would be contained in 2016's Form 14A ( the definitive proxy assertion ), as would the record of comparable firms utilized by Provectus' BOD's compensation committee.
Feel free to visit my web page ... oramed stock forum (http://masbukti.com/index.php/component/k2/itemlist/user/4967.html)
Simple Machines Forum | Propulsé par SMF 1.0.7.
© 2001-2005, Lewis Media. Tous droits réservés. |